Last week, Vanderbilt University Medical Center hosted “A Discussion with Mark Cuban: How Cost Plus Drugs Is Innovating to Lower Prescription Drug Prices in America.” The event took place at Monroe Carell Jr. Children’s Hospital at Vanderbilt. Cuban was joined by Professor of Health Policy Stacie Dusetzina, PhD, and VUMC Urologic Oncology fellow Ruchika Talwar, MD.
Cuban is a businessman who owns the Dallas Mavericks NBA team and is an investor on the ABC television show “Shark Tank.” He is also the founder of the online business Mark Cuban Cost Plus Drug Co., which offers prescription drugs at discounted prices.
The discussion explored implications of the Journal of Urology paper that shows Cuban’s new drug company could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on the nine most popular urological drugs. The study was authored by Talwar and Sam S. Chang, MD, MBA, Patricia and Rodes Hart Endowed Professor of Urologic Surgery and VUMC Chief Surgical Officer, Vanderbilt Ingram Cancer Center.
A recording of the discussion is available on Vanderbilt Health’s YouTube channel: https://www.youtube.com/watch?v=AHHiWfQTk5w
